Orai3 has been presented as an oncogene and plays an important role in supporting a number of hallmarks in different tumoral cell types, such as pancreatic adenocarcinoma, prostate and luminal breast cancer cells [48, 49, 50, 51]. Here, ORAI3 is linked to pancreatic adenocarcinoma.